This certified on-demand micro webcast covers the latest adjuvant treatment options for patients with high-risk, HR-positive/HER2-negative early breast cancer (EBC), including patient provider communication tactics to optimize personalized care.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
IPCE CreditsUp to 0.75 creditsAAPA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 12001 Sunrise Valley Dr.
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Foot & Ankle Surgery
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Laryngology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Transplant Surgery
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedMay 6, 2026
-
Last day to claim creditNov 6, 2026 4 weeks left
-
Medscape, LLC High-Risk HR-Positive, HER2-Negative Early Breast Cancer: Latest Updates from the European Oncology Congress
-
PVI, PeerView Institute for Medical Education Raising the Bar for Survival in High-Risk HR+, HER2- EBC: A Practical Framework for the Adjuvant Setting; Real-World Strategies to Improve Risk Assessment, Candidate Identification, Differentiated CDK4/6i + ET Selection, and Optimal Treatment Delivery
-
Medical Learning Institute, Inc. Oncologist Voices from the Frontline: Adjuvant CDK4/6 Therapy in HR+ HER2- Breast Cancer
-
Partners for Advancing Clinical Education Fundamentals II: Advancing Therapy in HR-Positive/ HER2-Negative Metastatic Breast Cancer
-
Partners for Advancing Clinical Education Fundamentals III: Targeted Therapy Options in HR-Positive/ HER2-Negative Breast Cancer
-
touchIME +1 HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers
